— Elayta Crossed Blood Brain Barrier and Reached CNS Levels Associated in Preclinical Studies with Cognitive Improvement — Pittsburgh, Feb. […]
Menu
Tag: Cognition Therapeutics
COGNITION THERAPEUTICS INITIATES NIA-FUNDED SPARC STUDY OF ELAYTA™ TO ASSESS CHANGES IN SYNAPTIC DENSITY AND COGNITIVE PERFORMANCE IN ALZHEIMER’S DISEASE
First Longitudinal Study of Novel Synaptic Imaging Agent at Yale Alzheimer’s Disease Research Unit and Yale PET Center PITTSBURGH, June […]
COGNITION THERAPEUTICS CEO KENNETH I. MOCH TO PRESENT AT THE STIFEL 2017 HEALTHCARE CONFERENCE
Pittsburgh, Nov. 08, 2017 – Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics […]